RIM
ANIK icon

Ranger Investment Management’s Anika Therapeutics ANIK Stock Holding History

Ranger Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-140,205
Closed -$4.15M – 104
2022
Q4 		$4.15M Buy
140,205
+3,079
+2% +$87.6K 0.31% 67
2022
Q3 		$3.26M Sell
137,126
-2,535
-2% -$58.3K 0.26% 70
2022
Q2 		$3.12M Buy
139,661
+3,280
+2% +$73.2K 0.24% 73
2022
Q1 		$3.42M Buy
136,381
+8,150
+6% +$248K 0.22% 69
2021
Q4 		$4.59M Buy
128,231
+12
+0% +$480 0.25% 66
2021
Q3 		$5.46M Buy
128,219
+6,695
+6% +$276K 0.29% 67
2021
Q2 		$5.26M Sell
121,524
-474
-0.4% -$20.2K 0.27% 63
2021
Q1 		$4.98M Buy
121,998
+46,003
+61% +$1.74M 0.27% 65
2020
Q4 		$3.44M Buy
75,995
+22,196
+41% +$842K 0.18% 71
2020
Q3 		$1.9M Buy
+53,799
New +$1.94M 0.12% 75
2015
Q2 		– Sell
-412,720
Closed -$17M – 128
2015
Q1 		$17M Buy
412,720
+1,280
+0.3% +$51.7K 0.83% 47
2014
Q4 		$16.8M Buy
411,440
+394,200
+2,287% +$15.4M 0.86% 46
2014
Q3 		$632K Buy
+17,240
New +$745K 0.03% 102

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ranger Investment Management's ANIK Position: Q1 2023 in Review

Ranger Investment Management sold out of Anika Therapeutics (ANIK) in Q1 2023, closing a stake of 140,205 shares — an estimated $4.15M sold.

Ranger Investment Management first reported a position in ANIK in Q3 2014 and held it in 13 quarters. The position peaked at $17M in Q1 2015. 120 funds tracked by Wall St. Rank hold ANIK as of Q1 2023.

  • Ranger Investment Management reported no remaining Anika Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Ranger Investment Management sold 140,205 Anika Therapeutics shares in Q1 2023, an estimated $4.15M.
  • Ranger Investment Management first reported a position in Anika Therapeutics in Q3 2014 and held it in 13 quarters.
  • Ranger Investment Management's Anika Therapeutics position peaked at $17M in Q1 2015.
  • 120 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2023.

Based on Ranger Investment Management's 13F filing for Q1 2023, filed 5 May 2023.